BRPI0910923A2 - peptídeo parcial de lacritina - Google Patents
peptídeo parcial de lacritinaInfo
- Publication number
- BRPI0910923A2 BRPI0910923A2 BRPI0910923-4A BRPI0910923A BRPI0910923A2 BR PI0910923 A2 BRPI0910923 A2 BR PI0910923A2 BR PI0910923 A BRPI0910923 A BR PI0910923A BR PI0910923 A2 BRPI0910923 A2 BR PI0910923A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- lacritine
- present
- sequence
- promote
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102100034719 Extracellular glycoprotein lacritin Human genes 0.000 title 1
- 101001090521 Homo sapiens Extracellular glycoprotein lacritin Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 230000028327 secretion Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000021164 cell adhesion Effects 0.000 abstract 1
- 210000004907 gland Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
peptídeo parcial de lacritina a presente invenção refere-se a um polipeptídeo tendo uma sequência parcial de lacritina, a qual é capaz de promover a adesão entre uma célula e uma matriz extracelular; e um polipeptídeo tendo uma 5 sequência parcial de lacritina, a qual tem uma ação para promover a secreção de fluido lacrimal. a presente invenção provê um polipeptídeo compreendendo uma sequência de aminoácido de seq id no: 1, a qual é uma sequência parcial particular de lacritina, e tendo um comprimento de aminoácido de não mais do que 70 resíduos. o polipeptídeo da presente invenção pode promover a adesão celular entre uma célula e uma matriz extracelular. o polipeptídeo da presente invenção pode promover a secreção do fluido lacrimal a partir das células acinares da glândula lacrimal.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008-071065 | 2008-03-19 | ||
| JP2008071065 | 2008-03-19 | ||
| PCT/JP2009/055489 WO2009116639A1 (ja) | 2008-03-19 | 2009-03-19 | ラクリチンの部分ペプチド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0910923A2 true BRPI0910923A2 (pt) | 2018-12-26 |
Family
ID=41091037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0910923-4A BRPI0910923A2 (pt) | 2008-03-19 | 2009-03-19 | peptídeo parcial de lacritina |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8383130B2 (pt) |
| EP (1) | EP2270141B9 (pt) |
| JP (1) | JP5475640B2 (pt) |
| KR (1) | KR20100137510A (pt) |
| CN (1) | CN102083974A (pt) |
| BR (1) | BRPI0910923A2 (pt) |
| CA (1) | CA2718706A1 (pt) |
| MX (1) | MX2010010213A (pt) |
| RU (1) | RU2010142486A (pt) |
| WO (1) | WO2009116639A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5716018B2 (ja) * | 2009-09-16 | 2015-05-13 | 千寿製薬株式会社 | ラクリチンの部分ペプチド |
| WO2011037196A1 (ja) * | 2009-09-25 | 2011-03-31 | 千寿製薬株式会社 | ラクリチン遺伝子の転写調節因子のスクリーニング方法 |
| GB201304829D0 (en) * | 2013-03-15 | 2013-05-01 | Petrowell Ltd | Method and apparatus |
| JP6987757B2 (ja) * | 2016-06-16 | 2022-01-05 | サンスター株式会社 | 新規トリペプチド |
| KR20190137788A (ko) * | 2017-02-21 | 2019-12-11 | 티얼솔루션즈, 인크. | 안정한 펩타이드 조성물 |
| KR102337935B1 (ko) * | 2019-04-18 | 2021-12-10 | 코스맥스 주식회사 | 라크리틴을 포함하는 피부장벽 개선 및 보습 증진용 화장료 조성물 |
| CN117143256B (zh) * | 2023-10-27 | 2024-01-26 | 英特菲尔(成都)生物制品有限责任公司 | 一种用于毛发修护的细胞外基质蛋白及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1395278B1 (en) | 2001-02-20 | 2009-07-15 | University Of Virginia Patent Foundation | Ocular tear growth factor-like protein |
| JP4745525B2 (ja) | 2001-05-09 | 2011-08-10 | 実 上田 | 角膜治療用培養上皮細胞シート及びその製造方法 |
| KR100940765B1 (ko) | 2001-11-19 | 2010-02-10 | 아르브라스트 가부시키가이샤 | 각막 상피형 시트, 및 그의 제조 방법 |
| JP3935096B2 (ja) | 2003-02-14 | 2007-06-20 | 株式会社セルシード | 高生着性角膜上皮代替細胞シート、製造方法及びその利用方法 |
| JP2004298447A (ja) | 2003-03-31 | 2004-10-28 | Menicon Co Ltd | 結膜上皮細胞からなる角膜ないし結膜治療用培養シート、およびその作製方法 |
| JP5122278B2 (ja) * | 2004-05-13 | 2013-01-16 | ユニバーシティ オブ バージニア パテント ファウンデーション | 眼細胞生存の促進におけるラクリチンの使用 |
| JP2008071065A (ja) | 2006-09-13 | 2008-03-27 | Hitachi Ltd | インライン展開を行うコンパイル装置、方法、プログラム、記憶媒体 |
| US20090312252A1 (en) * | 2006-09-14 | 2009-12-17 | University Of Virginia Patent Foundation | Antimicrobial Activity in Variants of Lacritin |
-
2009
- 2009-03-19 US US12/922,084 patent/US8383130B2/en not_active Expired - Fee Related
- 2009-03-19 CA CA2718706A patent/CA2718706A1/en not_active Abandoned
- 2009-03-19 KR KR1020107022979A patent/KR20100137510A/ko not_active Withdrawn
- 2009-03-19 WO PCT/JP2009/055489 patent/WO2009116639A1/ja not_active Ceased
- 2009-03-19 CN CN2009801094681A patent/CN102083974A/zh active Pending
- 2009-03-19 MX MX2010010213A patent/MX2010010213A/es active IP Right Grant
- 2009-03-19 RU RU2010142486/10A patent/RU2010142486A/ru not_active Application Discontinuation
- 2009-03-19 JP JP2010503936A patent/JP5475640B2/ja not_active Expired - Fee Related
- 2009-03-19 BR BRPI0910923-4A patent/BRPI0910923A2/pt not_active IP Right Cessation
- 2009-03-19 EP EP09722944.7A patent/EP2270141B9/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2270141A4 (en) | 2011-08-24 |
| EP2270141B9 (en) | 2015-12-16 |
| MX2010010213A (es) | 2010-10-05 |
| CN102083974A (zh) | 2011-06-01 |
| EP2270141A1 (en) | 2011-01-05 |
| KR20100137510A (ko) | 2010-12-30 |
| US20110008891A1 (en) | 2011-01-13 |
| EP2270141B1 (en) | 2015-05-27 |
| RU2010142486A (ru) | 2012-04-27 |
| WO2009116639A1 (ja) | 2009-09-24 |
| CA2718706A1 (en) | 2009-09-24 |
| JP5475640B2 (ja) | 2014-04-16 |
| JPWO2009116639A1 (ja) | 2011-07-21 |
| US8383130B2 (en) | 2013-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0910923A2 (pt) | peptídeo parcial de lacritina | |
| ES2539812T3 (es) | Péptidos derivados de PRAME y composiciones inmunogénicas que comprenden los mismos | |
| ES2559062T3 (es) | Método para la activación de linfocitos T colaboradores y composición para su uso en el método | |
| ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
| ES2545895T3 (es) | Proteína de fusión anticancerígena | |
| CO6491059A2 (es) | Diferenciacion de las celulas madre mesenquimales | |
| ES2534744T3 (es) | Plasmina modificada de forma recombinante | |
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| BR112013032630A2 (pt) | polipeptídeo heterodimerizado | |
| UA103215C2 (uk) | Поліпептид з ксиланазною активністю | |
| PE20070033A1 (es) | Concentrado de proteina y flujo acuoso que contiene carbohidratos solubles de agua | |
| UA103216C2 (uk) | Поліпептид з ксиланазною активністю | |
| EA201000327A1 (ru) | Белок | |
| CL2012000063A1 (es) | Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07). | |
| BR112014027283A2 (pt) | variantes de enzima aprimoradas | |
| UY30984A1 (es) | Proteinas de fusion de formula m-a para degradar péptidos beta amiloides, composiciones en base a ella, preparacion y aplicaciones. | |
| BR112016010643A2 (pt) | peptídeo | |
| CO6290699A2 (es) | Termoestabilizacion de proteinas | |
| AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
| BR112016017349A2 (pt) | métodos para melhorar os subprodutos de processos de fermentação usando xilanase | |
| BRPI0715331B8 (pt) | polipeptídeo que compreende uma porção n-terminal e uma porção c-terminal, e uso do mesmo | |
| WO2008105178A1 (ja) | リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム | |
| BR112013025975A2 (pt) | proteína de fusão anticancerígena | |
| BRPI0608273A2 (pt) | peptìdeos para diminuição da pressão sanguìnea a partir de glicomacropeptìdeo | |
| EA201590431A1 (ru) | Пшеница с новыми аллелями rht-b1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS ANUIDADES EM DEBITO. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2504 DE 02-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |